Cite

HARVARD Citation

    Cepika, A. et al. (n.d.). 146 Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1. Journal for immunotherapy of cancer. p. A88. [Online]. 
  
Back to record